Minimal hepatic encephalopathy may be present despite the absence of non-invasive and elastography evidence of cirrhosis in patients with primary biliary cholangitis

2017, Electronic address: [email protected]; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis, J Hepatol, 67, 145, 10.1016/j.jhep.2017.03.022 Selmi, 2011, Primary biliary cirrhosis, Lancet, 377, 1600, 10.1016/S0140-6736(10)61965-4 Sayiner, 2019, Primary biliary cholangitis in medicare population: the impact on mortality and resource use, Hepatology, 69, 237, 10.1002/hep.30174 Tranah, 2015, Pathophysiological mechanisms of hepatic encephalopathy, Clin Liver Dis, 5, 59, 10.1002/cld.445 Coltart, 2013, Inflammation and hepatic encephalopathy, Arch Biochem Biophys, 536, 189, 10.1016/j.abb.2013.03.016 Zemtsova, 2011, Microglia activation in hepatic encephalopathy in rats and humans, Hepatology, 54, 204, 10.1002/hep.24326 Shawcross, 2007, Role of ammonia and inflammation in minimal hepatic encephalopathy, Metab Brain Dis, 22, 125, 10.1007/s11011-006-9042-1 Shawcross, 2004, Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis, J Hepatol, 40, 247, 10.1016/j.jhep.2003.10.016 Cauli, 2007, Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts, Hepatology, 46, 514, 10.1002/hep.21734 Rodrigo, 2010, Hyperammonemia induces neuroinflammation that contributes to cognitive impairment in rats with hepatic encephalopathy, Gastroenterology, 139, 675, 10.1053/j.gastro.2010.03.040 Montoliu, 2009, IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy, J Clin Gastroenterol, 43, 272, 10.1097/MCG.0b013e31815e7f58 Felipo, 2012, Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy, Metab Brain Dis, 27, 51, 10.1007/s11011-011-9269-3 Bale, 2018, Prevalence of and factors associated with minimal hepatic encephalopathy in patients with cirrhosis of liver, J Clin Exp Hepatol, 8, 156, 10.1016/j.jceh.2017.06.005 Rogalski, 2019, Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding, Thromb Res, 178, 41, 10.1016/j.thromres.2019.03.021 Rogalski, 2019, Blood platelet function abnormalities in cirrhotic patients with esophageal varices in relation to the variceal bleeding history, Scand J Gastroenterol, 1 Weissenborn, 2015, The clinical relevance of minimal hepatic encephalopathy--A critical look, Dig Dis, 33, 555, 10.1159/000375348 Kamath, 2001, A model to predict survival in patients with end-stage liver disease, Hepatology, 33, 464, 10.1053/jhep.2001.22172 Child, 1964, Surgery and portal hypertension, Major Probl Clin Surg, 1, 1 Brown, 2002, Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients, Liver Transplant, 8, 278, 10.1053/jlts.2002.31340 Weissenborn, 2015, Diagnosis of minimal hepatic encephalopathy, J Clin Exp Hepatol, 5, S54, 10.1016/j.jceh.2014.06.005 Cosgrove, 2013, EFSUMB guidelines and recommendations on the clinical use of ultrasound elastography. Part 2: clinical applications, Ultraschall der Med, 34, 238, 10.1055/s-0033-1335375 Ferraioli, 2015, WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver, Ultrasound Med Biol, 41, 1161, 10.1016/j.ultrasmedbio.2015.03.007 Mare, 2017, The value of ElastPQ for the evaluation of liver stiffness in patients with B and C chronic hepatopathies, Ultrasonics, 77, 144, 10.1016/j.ultras.2017.02.005 Lin, 2011, Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis, Hepatology, 53, 726, 10.1002/hep.24105 Olmez, 2016, The relationship between liver histology and noninvasive markers in primary biliary cirrhosis, Eur J Gastroenterol Hepatol, 28, 773, 10.1097/MEG.0000000000000637 Sterling, 2006, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, 43, 1317, 10.1002/hep.21178 Maldonado-Garza, 2011, Prevalence of minimal hepatic encephalopathy in cirrhotic patients, Ann Hepatol, 10, S40, 10.1016/S1665-2681(19)31605-9 Mina, 2014, Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis, Hepatol Res, 44, E92, 10.1111/hepr.12227 Wang, 2013, Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China, World J Gastroenterol, 19, 4984, 10.3748/wjg.v19.i30.4984 Dhand Rathi, 2019, Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: a cross-sectional, clinicoepidemiological, multicenter, nationwide study in India: the predict study, J Clin Exp Hepatol, 9, 476, 10.1016/j.jceh.2018.09.009 Sharma, 2012, Minimal hepatic encephalopathy in patients with cirrhosis by measuring liver stiffness and hepatic venous pressure gradient, Saudi J Gastroenterol, 18, 316, 10.4103/1319-3767.101126 Czaja, 1998, Frequency and nature of the variant syndromes of autoimmune liver disease, Hepatology, 28, 360, 10.1002/hep.510280210 Poupon, 2006, Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis, Hepatology, 44, 85, 10.1002/hep.21229 Bonder, 2011, Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome, Clin Gastroenterol Hepatol, 9, 609, 10.1016/j.cgh.2011.03.019 Labenz, 2019, Development and validation of a prognostic score to predict covert hepatic encephalopathy in patients with cirrhosis, Am J Gastroenterol, 114, 764, 10.14309/ajg.0000000000000121